Relevium Issues Important Clarification About Bioganix CleanCare Brand
June 23 2020 - 2:49PM
Relevium Technologies Inc. (TSX.V: “RLV”, OTC: “RLLVF” and
Frankfurt: “6BX”) (the “Company” or “Relevium”), is pleased to
provide an important clarification about Bioganix CleanCare, its
brand of disinfection and wellness products.
On. June 19, 2020, the FDA issued a public
health warning about nine (9) hand sanitizers manufactured by
Eskbiochem SA, four (4) “CleanCare No Germ Advanced” branded
products that could contain potentially dangerous chemicals.
This FDA warning about Eskbiochem SA is
100% UNRELATED to BIOGANIX CLEANCARE.
Relevium and its executive team would like to
provide comfort to its customers and shareholders that there is
ZERO relation between Bioganix CleanCare, the nine products
recalled and its manufacturer, who uses a similar name for some of
its products.
Our Bioganix CleanCare disinfection products are
manufactured at our partner contract manufacturers located in the
US and Canada. Bioganix only contracts FDA and Health Canada
approved facilities, following good manufacturing practices and the
Bioganix CleanCare disinfection products are formulated using only
accepted medical grade ingredients that meet or exceeded national
and international standards.
Aurelio Useche CEO of Relevium stated: “We are
very pleased to be able to distance ourselves from any product and
manufacturer that does not meet top tier status for quality and
safety track record. Our investors and customers alike can rest
assured that our products meet the highest level of quality in
terms of ingredients, manufacturing process and formulation”
Aurelio Useche stated further: “There is ZERO
link between Bioganix CleanCare and ANY other CleanCare branded
product in the market. There is only ONE Bioganix CleanCare and we
stand behind our brand and its tradition for excellence”
Neither the TSX Venture Exchange nor its
Regulation Services Provider (as that term is defined in policies
of the TSX Venture Exchange) accepts responsibility for the
adequacy or accuracy of this
release.
About Relevium Technologies
Relevium is a publicly traded Company that
operates in the health and wellness industry, including legal
cannabis, with a primary focus on online distribution. The
principal business of the Company is the identification,
evaluation, acquisition and operation of brands and businesses in
the health and wellness markets and medical cannabis. The Company
pursues its business strategy through an acquisition and
partnership model in a holistic approach to encompass a wide range
of health and wellness consumer products. Relevium operates through
two wholly owned subsidiaries:
BGX E-Health LLC (BGX), based in Orlando,
Florida, markets dietary supplements, nutraceuticals, sports
nutrition, and cosmeceuticals primarily through its Bioganix® brand
portfolio in the US and Europe.
Relevium’s premium brands are sold at some of
the world’s largest retailers including Walmart.com and
Amazon.com.
Biocannabix Health Corporation (BCX), based in
Montreal, Quebec, is a biopharma nutraceutical Company focused on
delivering pediatric endo-medicinal nutraceuticals for cannabinoid
therapy.
Cautionary Note Regarding
Forward-Looking Statements
This release includes certain statements and
information that may constitute forward-looking information within
the meaning of applicable Canadian and United States securities
laws. All statements in this news release, other than statements of
historical facts, including statements regarding future estimates,
plans, objectives, assumptions, or expectations of future
performance, are forward-looking statements and contain
forward-looking information. Generally, forward- looking statements
and information can be identified by the use of forward-looking
terminology such as "intends" or "anticipates", or variations of
such words and phrases or statements that certain actions, events
or results "may", "could", "should", or "would" occur.
Forward-looking statements are based on certain material
assumptions and analysis made by the Company and the opinions and
estimates of management as of the date of this press release. These
forward-looking statements are subject to known and unknown risks,
uncertainties and other factors that may cause the actual results,
level of activity, performance or achievements of the Company to be
materially different from those expressed or implied by such
forward-looking statements or forward-looking information.
Although management of the Company has attempted
to identify important factors that could cause actual results to
differ materially from those contained in forward-looking
statements or forward-looking information, there may be other
factors that cause results not to be as anticipated, estimated or
intended. There can be no assurance that such statements will prove
to be accurate, as actual results and future events could differ
materially from those anticipated in such statements. Accordingly,
readers should not place undue reliance on forward- looking
statements and forward-looking information. Readers are cautioned
that reliance on such information may not be appropriate for other
purposes. The Company does not undertake to update any
forward-looking statement, forward-looking information or financial
outlook that are incorporated by reference herein, except in
accordance with applicable securities laws. We seek to rely on the
applicable safe harbor.
On Behalf of the Board of Directors
RELEVIUM TECHNOLOGIES
INC.
Aurelio UsechePresident and CEO
For more information about this press
release:
Tel: +1.888.528.8687
RELEVIUM TECHNOLOGIES
INC
Email: investors@releviumcorp.com Website:
www.releviumtechnologies.com Like us on FacebookFollow us on
Twitter Follow us on LinkedIn
Relevium Technologies (TSXV:RLV)
Historical Stock Chart
From Jun 2024 to Jul 2024
Relevium Technologies (TSXV:RLV)
Historical Stock Chart
From Jul 2023 to Jul 2024